PMC:7102591 / 13143-13385
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"424","span":{"begin":63,"end":67},"obj":"Gene"},{"id":"425","span":{"begin":90,"end":94},"obj":"Species"},{"id":"426","span":{"begin":228,"end":236},"obj":"Species"},{"id":"427","span":{"begin":0,"end":9},"obj":"Chemical"},{"id":"430","span":{"begin":81,"end":89},"obj":"Disease"},{"id":"431","span":{"begin":198,"end":206},"obj":"Disease"},{"id":"432","span":{"begin":207,"end":216},"obj":"Disease"}],"attributes":[{"id":"A424","pred":"tao:has_database_id","subj":"424","obj":"Gene:302668"},{"id":"A425","pred":"tao:has_database_id","subj":"425","obj":"Tax:10116"},{"id":"A426","pred":"tao:has_database_id","subj":"426","obj":"Tax:9606"},{"id":"A427","pred":"tao:has_database_id","subj":"427","obj":"MESH:D007052"},{"id":"A430","pred":"tao:has_database_id","subj":"430","obj":"MESH:D003920"},{"id":"A431","pred":"tao:has_database_id","subj":"431","obj":"MESH:C000657245"},{"id":"A432","pred":"tao:has_database_id","subj":"432","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Ibuprofen has been demonstrated to induce an overexpression of ACE2 when used in diabetic rats [50] and this effect might theoretically increase the susceptibility and worsen the clinical course of COVID-19 infection in treated patients [15]."}
LitCovid_AGAC
{"project":"LitCovid_AGAC","denotations":[{"id":"p51590s23","span":{"begin":136,"end":144},"obj":"PosReg"}],"text":"Ibuprofen has been demonstrated to induce an overexpression of ACE2 when used in diabetic rats [50] and this effect might theoretically increase the susceptibility and worsen the clinical course of COVID-19 infection in treated patients [15]."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T174","span":{"begin":198,"end":206},"obj":"Disease"},{"id":"T175","span":{"begin":207,"end":216},"obj":"Disease"}],"attributes":[{"id":"A174","pred":"mondo_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A175","pred":"mondo_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Ibuprofen has been demonstrated to induce an overexpression of ACE2 when used in diabetic rats [50] and this effect might theoretically increase the susceptibility and worsen the clinical course of COVID-19 infection in treated patients [15]."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T100","span":{"begin":10,"end":13},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"Ibuprofen has been demonstrated to induce an overexpression of ACE2 when used in diabetic rats [50] and this effect might theoretically increase the susceptibility and worsen the clinical course of COVID-19 infection in treated patients [15]."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T106","span":{"begin":0,"end":9},"obj":"Chemical"}],"attributes":[{"id":"A106","pred":"chebi_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/CHEBI_5855"}],"text":"Ibuprofen has been demonstrated to induce an overexpression of ACE2 when used in diabetic rats [50] and this effect might theoretically increase the susceptibility and worsen the clinical course of COVID-19 infection in treated patients [15]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T69","span":{"begin":0,"end":242},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ibuprofen has been demonstrated to induce an overexpression of ACE2 when used in diabetic rats [50] and this effect might theoretically increase the susceptibility and worsen the clinical course of COVID-19 infection in treated patients [15]."}
2_test
{"project":"2_test","denotations":[{"id":"32205186-25896805-4826891","span":{"begin":96,"end":98},"obj":"25896805"}],"text":"Ibuprofen has been demonstrated to induce an overexpression of ACE2 when used in diabetic rats [50] and this effect might theoretically increase the susceptibility and worsen the clinical course of COVID-19 infection in treated patients [15]."}